18 November 2024
18 November 2024
The trial met its primary safety and efficacy endpoints, demonstrating the device's superiority to oral anticoagulants.
The software is designed to improve the accuracy of detecting morphological abnormalities during foetal heart ultrasound exams.
Alzheimer’s trials face the unique challenge of studying participants with cognitive decline, amid a move towards digital technologies.
Inflation and geopolitical conflict are uppermost among the priorities of businesses for the coming 12 months, ahead of ESG.
While Trump and Robert F Kennedy Jr have named the FDA as a target of particular interest for deregulation efforts, much of the rhetoric surrounds pharmaceutical companies and products.
RPM devices are poised to become a cornerstone of healthcare for patients around the globe.
Tivic has not yet identified clinical targets as the company optimises its non-invasive technology.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
